Published in Cutis on August 01, 2006
Moisturizers for Acne: What are their Constituents? J Clin Aesthet Dermatol (2014) 0.87
Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol (2006) 1.43
The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol (2011) 1.40
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22
Dermatofibrosarcoma protuberans: a case report and review of the literature. J Clin Aesthet Dermatol (2008) 1.16
Atypical mycobacterial cutaneous infections. Dermatol Clin (2009) 1.15
Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol (2010) 1.13
Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol (2013) 1.08
Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol (2011) 1.07
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis (2007) 1.03
A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol (2010) 1.02
Aesthetic dermatology for aging ethnic skin. Dermatol Surg (2011) 1.01
Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol (2009) 0.98
Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol (2013) 0.98
Anti-inflammatory activity of tetracyclines. Dermatol Clin (2007) 0.98
Calciphylaxis: a review. J Clin Aesthet Dermatol (2008) 0.98
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction. Dermatol Surg (2016) 0.94
Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol (2010) 0.92
Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol (2009) 0.92
Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. J Clin Aesthet Dermatol (2012) 0.92
Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol (2009) 0.92
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin (2009) 0.91
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? J Clin Aesthet Dermatol (2013) 0.90
A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol (2009) 0.89
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. J Cosmet Laser Ther (2004) 0.88
Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations. Biopsychosoc Med (2011) 0.87
Skin cancer in asians: part 2: melanoma. J Clin Aesthet Dermatol (2009) 0.87
Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. J Drugs Dermatol (2011) 0.86
Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol (2008) 0.85
An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. Cutis (2013) 0.85
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis (2007) 0.85
Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction. Cutis (2009) 0.85
Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis. J Clin Aesthet Dermatol (2011) 0.85
Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol (2013) 0.84
Solitary sclerotic fibroma. J Clin Aesthet Dermatol (2009) 0.84
Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne. J Drugs Dermatol (2008) 0.84
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. Cutis (2014) 0.83
Healthcare utilization and costs of patients with rosacea in an insured population. J Drugs Dermatol (2008) 0.83
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. Cutis (2013) 0.83
Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study. J Cosmet Laser Ther (2006) 0.83
Acne in ethnic skin. Dermatol Clin (2003) 0.83
Comprehensive medical management of rosacea: an interim study report and literature review. J Clin Aesthet Dermatol (2008) 0.83
Differentiating central centrifugal cicatricial alopecia and androgenetic alopecia in african american men: report of three cases. J Clin Aesthet Dermatol (2012) 0.82
Skin cancer in asians: part 1: nonmelanoma skin cancer. J Clin Aesthet Dermatol (2009) 0.81
Modulation of gene expression as a new skin anti-aging strategy. J Drugs Dermatol (2007) 0.81
Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light. J Clin Aesthet Dermatol (2012) 0.80
Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%). J Clin Aesthet Dermatol (2010) 0.80
Efficacy of hydroquinone-free skin-lightening cream for photoaging. J Cosmet Dermatol (2013) 0.80
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. Cutis (2009) 0.79
Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol (2011) 0.79
Tinea capitis in infants: recognition, evaluation, and management suggestions. J Clin Aesthet Dermatol (2012) 0.79
A status report on topical tazarotene in the management of acne vulgaris. J Drugs Dermatol (2013) 0.79
Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses. J Clin Aesthet Dermatol (2009) 0.79
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. J Clin Aesthet Dermatol (2013) 0.79
Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy. Dermatol Clin (2007) 0.78
Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. J Clin Aesthet Dermatol (2011) 0.78
Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol (2011) 0.78
A multicenter study of the safety and effectiveness of hyaluronic acid with a cohesive polydensified matrix for treatment of nasolabial folds in subjects with Fitzpatrick skin types IV, V, and VI. Plast Reconstr Surg (2013) 0.78
Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study. J Drugs Dermatol (2009) 0.78
Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris. Cutis (2007) 0.78
Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial. Dermatol Surg (2009) 0.78
Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications. J Drugs Dermatol (2016) 0.77
Prevalence and etiology of central centrifugal cicatricial alopecia. Arch Dermatol (2011) 0.77
Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs Dermatol (2013) 0.77
Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices. Cutis (2014) 0.77
Evolving perspectives on the etiology and pathogenesis of acne vulgaris. J Drugs Dermatol (2015) 0.77
Ability of moisturizers to reduce dry skin and irritation and to prevent their return. J Cosmet Sci (2006) 0.77
Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach. J Clin Aesthet Dermatol (2010) 0.77
Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment - Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel. J Drugs Dermatol (2015) 0.77
AbobotulinumtoxinA for reduction of glabellar lines in patients with skin of color: post hoc analysis of pooled clinical trial data. Dermatol Surg (2012) 0.76
Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol (2014) 0.76
Optimal management of papulopustular rosacea: rationale for combination therapy. J Drugs Dermatol (2012) 0.76
Hair and scalp disorders in ethnic populations. J Drugs Dermatol (2013) 0.76
The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician? J Drugs Dermatol (2013) 0.76
A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne. J Drugs Dermatol (2014) 0.75
The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color. J Drugs Dermatol (2016) 0.75
A status report on drug-associated acne and acneiform eruptions. J Drugs Dermatol (2010) 0.75
Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. J Clin Aesthet Dermatol (2009) 0.75
Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol (2010) 0.75
Primary carcinosarcoma of the ear: case report and review of the literature. J Clin Aesthet Dermatol (2009) 0.75
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies. Cutis (2014) 0.75
A new proprietary onion extract gel improves the appearance of new scars: a randomized, controlled, blinded-investigator study. J Clin Aesthet Dermatol (2012) 0.75
Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review. J Clin Aesthet Dermatol (2009) 0.75
A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne. J Clin Aesthet Dermatol (2010) 0.75
Avoiding the legal "blemish": medicolegal pitfalls in dermatology. J Clin Aesthet Dermatol (2009) 0.75
Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study. J Clin Aesthet Dermatol (2008) 0.75
Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications. J Clin Aesthet Dermatol (2010) 0.75
A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne. J Clin Aesthet Dermatol (2009) 0.75
A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses. J Clin Aesthet Dermatol (2012) 0.75
Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin. J Clin Aesthet Dermatol (2013) 0.75
Topical retinoids in the management of acne: the best path to clear results. Cutis (2004) 0.75
Topical tazarotene in acne vulgaris: treatment approaches. Cutis (2004) 0.75
Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it. J Drugs Dermatol (2011) 0.75
What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. J Drugs Dermatol (2013) 0.75
Acne and rosacea. J Drugs Dermatol (2008) 0.75
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. J Drugs Dermatol (2006) 0.75
Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J Drugs Dermatol (2013) 0.75
Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction. J Drugs Dermatol (2008) 0.75